Genoss Co., Ltd.
Clinical trials sponsored by Genoss Co., Ltd., explained in plain language.
-
New balloon treatment for leg artery disease shows promise in Real-World study
Disease control ENROLLING_BY_INVITATIONThis study is following 300 people with blocked leg arteries who received a special balloon coated with a drug (paclitaxel) to open the vessel. The goal is to see if the balloon keeps the artery open for at least a year without major problems like amputation or needing another pr…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:23 UTC
-
New balloon treatment aims to keep leg arteries open longer
Disease control ENROLLING_BY_INVITATIONThis study looks at how well a special balloon coated with a drug (paclitaxel) works for people with narrowed or blocked arteries in the leg. About 200 adults with leg pain or wounds will be followed for 12 months to see if the balloon keeps the artery open and prevents the need …
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:23 UTC
-
New heart stent under study in over 1,100 patients
Disease control OngoingThis study looks at how well a stent called GENOSS SES works in people with coronary artery disease. About 1,118 adults who already received the stent are being followed to track heart-related events like heart attack or need for another procedure. The goal is to see if the stent…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:20 UTC
-
New stent aims to keep hearts beating strong in Multi-Artery disease
Disease control ENROLLING_BY_INVITATIONThis study is tracking 1,000 adults with multivessel coronary artery disease (blockages in more than one heart artery) who receive the GENOSS® DES stent during a procedure to open their arteries. The goal is to see how safe and effective this stent is at preventing heart-related …
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:16 UTC
-
New heart stent aims to keep arteries open longer
Disease control ENROLLING_BY_INVITATIONThis study is testing a new type of stent (a small mesh tube) coated with a drug that slowly releases to keep heart arteries open. The stent's coating dissolves over time, which may reduce long-term risks. About 1000 adults with coronary artery disease who need a stent will take …
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New stent under observation for heart attack patients
Disease control OngoingThis study looks at how well the GENOSS stent works in 757 people with acute coronary syndrome, a serious heart condition. Participants received the stent during a procedure to open blocked arteries. Researchers track heart-related deaths, heart attacks, and the need for repeat p…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New stent aims to keep heart arteries open longer
Disease control ENROLLING_BY_INVITATIONThis study compares a new stent (Genoss SCB) to an existing one (SeQuent Please NEO) in 94 people whose heart arteries have re-narrowed after a previous stent. The main goal is to see which stent keeps the artery more open 6 months later. Participants must be at least 19 years ol…
Phase: NA • Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New balloon treatment could unclog tiny heart arteries without surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a special balloon coated with a drug (paclitaxel) and natural ingredients (shellac and vitamin E) to treat narrowed small heart arteries. About 3000 adults with new blockages in small arteries will receive this balloon treatment during a standard procedure. The g…
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC